Literature DB >> 10385216

Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats.

Z Li1, Y Y Guo, C F Wu, X Li, J H Wang.   

Abstract

This study assessed the effects of pseudoginsenoside-F11, a component of Panax quinquefolium L., on scopolamine-impaired memory performance in mice and rats. In the one-trial step-down and step-through passive avoidance tests, although pseudo-ginsenoside-F11 used alone did not affect passive avoidance behaviour in naive mice, the latency of avoidance shortened by intraperitoneal scopolamine (2 mg kg(-1)) was prolonged after intragastric administration of pseudoginsenoside-F11 (2 or 4 mg kg(-1), for five days) in both test systems in mice. In the water-maze test, in mice, the time taken to locate the platform after administration of pseudoginsenoside-F11 was shorter than that after administration of scopolamine (1 mg kg(-1), i.p.). In the two-way active avoidance response test, the latency of avoidance was significantly shorter for the pseudoginsenoside-F11-(1.2 or 2.4 mg kg(-1), i.g. for five days) and scopolamine-treated group than for the group of rats given scopolamine only (2 mg kg(-1), i.p.). The percentage avoidance was also reduced after intraperitoneal injection of scopolamine, but was reversed by administration of pseudo-ginsenoside-F11. These results suggest that pseudoginsenoside-F11 antagonized the memory dysfunction induced by scopolamine. However, the mechanism of the memory facilitative action of pseudoginsenoside-F11 merits further elucidation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385216     DOI: 10.1211/0022357991772484

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Ginseng derivative ocotillol enhances neuronal activity through increased glutamate release: a possible mechanism underlying increased spontaneous locomotor activity of mice.

Authors:  Z-J Wang; L Sun; W Peng; S Ma; C Zhu; F Fu; T Heinbockel
Journal:  Neuroscience       Date:  2011-08-12       Impact factor: 3.590

2.  Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.

Authors:  Kequan Fu; Huiyang Lin; Yoshiaki Miyamoto; Chunfu Wu; Jingyu Yang; Kyosuke Uno; Atsumi Nitta
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

3.  Modulation of nitrergic signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations.

Authors:  Puneet Rinwa; Anil Kumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-17       Impact factor: 3.000

4.  Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.

Authors:  Lei Zhu; Xiao-Jie Hou; Xiao-Hang Che; Ting-Shuo Zhou; Xiao-Qi Liu; Chun-Fu Wu; Jing-Yu Yang
Journal:  Acta Pharmacol Sin       Date:  2020-12-04       Impact factor: 7.169

5.  Pseudoginsenoside F11, a Novel Partial PPAR γ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes.

Authors:  Guoyu Wu; Junyang Yi; Ling Liu; Pengcheng Wang; Zhijie Zhang; Zhen Li
Journal:  PPAR Res       Date:  2013-12-18       Impact factor: 4.964

6.  Neuroprotective effect of pseudoginsenoside-f11 on a rat model of Parkinson's disease induced by 6-hydroxydopamine.

Authors:  Jian Yu Wang; Jing Yu Yang; Fang Wang; Shi Yuan Fu; Yue Hou; Bo Jiang; Jie Ma; Cui Song; Chun Fu Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-10       Impact factor: 2.629

7.  American ginseng regulates gene expression to protect against premature ovarian failure in rats.

Authors:  Lei Zhu; Ji Li; Nannan Xing; Dongwei Han; Haixue Kuang; Pengling Ge
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 8.  Discovery, semisynthesis, biological activities, and metabolism of ocotillol-type saponins.

Authors:  Juan Liu; Yangrong Xu; Jingjing Yang; Wenzhi Wang; Jianqiang Zhang; Renmei Zhang; Qingguo Meng
Journal:  J Ginseng Res       Date:  2017-01-13       Impact factor: 6.060

Review 9.  Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study.

Authors:  Md Jakaria; Md Ezazul Haque; Joonsoo Kim; Duk-Yeon Cho; In-Su Kim; Dong-Kug Choi
Journal:  Oncotarget       Date:  2018-09-11

10.  Actoprotective effect of ginseng: improving mental and physical performance.

Authors:  Sergiy Oliynyk; Seikwan Oh
Journal:  J Ginseng Res       Date:  2013-04       Impact factor: 6.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.